Adagio Therapeutics burst onto the scene in 2020 led by biotech veteran Tillman Gerngross, Ph.D., and in direct response to the COVID pandemic. But in the intervening years, much has changed at the ...

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at ...

The latest feature from writer-director Stefano Sollima stars a trio of Italy’s finest actors as men on opposite sides of the law. By Jordan Mintzer Adagio, as many musicians know, means “slowly” in ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that ...

New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia Early Feasibility Outcomes in a ...

WALTHAM, Mass.--(BUSINESS WIRE)--Adagio Therapeutics, Inc., a biotechnology company developing best-in-class antibodies to broadly neutralize coronaviruses, today announced the completion of a $336 ...

Adagio Therapeutics has nabbed a massive $336 million series C from a who’s who of investors as it more than triples its previous funding drive last year. The company raised $50 million in its debut ...

Tillman Gerngross has a simple goal: he wants to find one antibody that can both treat and prevent Covid-19, no matter how much the virus mutates. While many biotech companies are obsessed with making ...